Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia

NCT07714512 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia

Interventions

DRUG: Isatuximab

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]